Nephrology and Renal Diseases最新文献_第3页

Management of acute renal failure secondary to a renal infarction and renal thrombosis in a monorenal 76-year-old patient 76岁单肾患者继发于肾梗死和肾血栓的急性肾功能衰竭的处理

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000170

I. Romaniouk, I. Ortí, A. Martínez, M. Mravcová, B. Sánchez, M. Aparicio, R. Borrás, J. Ribes, Y. Aznar, Y. Blanco, E. Bea, J. Graña, B. González, M. Candel

引用次数: 0

β2M shuttle hypothesis in the dialysis related amyloidosis (DRA) 透析相关淀粉样变性(DRA)的β2M穿梭假说

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000157

Y. Motomiya, Y. Uji, Y. Ando

引用次数: 0

Anti-glomerular basement membrane disease case series in Trinidad and Tobago 特立尼达和多巴哥抗肾小球基底膜病病例系列

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000179

E. Mohammed, A. Ramrattan, P. Poon-king, A. Bissessar, A. Ramesar, S. Giddings, Av Rao

引用次数: 0

Experience of COVID 19 disease on 159 Ecuadorian chronic dialysis patients 159例厄瓜多尔慢性透析患者COVID - 19感染体会

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000174

J. C. Santacruz, A. Santacruz, Ana K Vásquez, P. Reinoso, C. Sulbarán, María G Santacruz

{"title":"Experience of COVID 19 disease on 159 Ecuadorian chronic dialysis patients","authors":"J. C. Santacruz, A. Santacruz, Ana K Vásquez, P. Reinoso, C. Sulbarán, María G Santacruz","doi":"10.15761/nrd.1000174","DOIUrl":"https://doi.org/10.15761/nrd.1000174","url":null,"abstract":"Aim: In December 2019, first Covid-19 disease cases were reported. The pandemic spread with 42,039,763 cases and 1,141,223 deaths worldwide with 156,451 confirmed cases and 12,500 deaths in Ecuador. The aim of this work is to share characteristics and clinical outcomes of 159 dialysis patients in Quito during pandemic. Materials and methods: Observational-prospective-unicenter study. Fifty-six consecutive patients (35%) presented COVID19 symptoms and followed since April to 30 September 2020. Positive nasopharyngeal PCR testing confirmed diagnosis. Low oxygen saturation (LOS) classified disease as severe, moderate if symptoms without LOS and asymptomatic if no symptoms. Hospital-stay, time disease, mortality, contagious rate data were collected. Results: Thirty-seven patients (23.3%) tested positive. Patients with LOS at presentation and hospitalized were older when compared with those without LOS (61.6 ± 11.9 vs 48.9 ± 11.9 years; p=0.02) and non-hospitalized (60.3 ± 12.7 vs 51.4 ± 15.6 years; p=0.02). Ten died (27%), mortality was significative in patients with previous pulmonary disease (p=0.01), LOS (p=0.03), hospitalization (p=0.01), and severe disease (p=0.03). Median hospital stay was 7 days (3-13), time disease was 17 days (6-25) and 10 days (6-22) until death. Conclusion: COVID-19 disease has increased mortality and health care demand in dialysis patients. Mortality was inferior to other series, and significative when previous pulmonary pathology, low oxygen saturation, hospitalization and severe disease were present. *Correspondence to: Juan C Santacruz, Nephrology and dialysis unit, Menydial Kidneys Clinic, Quito-Ecuador, Tel: 593979037586; E-mail: geovas40@hotmail.com","PeriodicalId":160607,"journal":{"name":"Nephrology and Renal Diseases","volume":"114 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117097461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Lithium nephrotoxicity: when and why? Experience of nephrology and psychiatry outpatient clinics 锂肾毒性:何时及为何?有肾内科和精神科门诊经验

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000192

Martin Scoglio, B. Vogt, A. Foglia, Claudia Paola Ferrier-Guerra

引用次数: 0

Natural health wellness: an effective prevention of DKD 天然健康养生:有效预防DKD

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000156

N. Futrakul, P. Futrakul

引用次数: 0

Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with uncomplicated recurrent urinary tract infections 无并发症复发性尿路感染患者解脲原体、人支原体和沙眼衣原体的患病率

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000150

J. Vlasić-Matas, H. Raos, M. Vučković, Stjepan Radić, V. Čapkun

{"title":"Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with uncomplicated recurrent urinary tract infections","authors":"J. Vlasić-Matas, H. Raos, M. Vučković, Stjepan Radić, V. Čapkun","doi":"10.15761/nrd.1000150","DOIUrl":"https://doi.org/10.15761/nrd.1000150","url":null,"abstract":"Aim: To assess the prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with chronic urinary tract infections (UTIs) and its correlation with leukocyturia and symptoms. Methods: The study included 220 patients (130 women and 90 men) presenting with chronic voiding symptoms and sterile leukocyturia. Urine, urethral swabs and cervical swabs (for women patients) were taken to determine the presence of these pathogens. Patients were treated by tetracycline and followed up three and six months after initial therapy. Results: In 186 (85%) out of 220 patients, U. urealyticum was found, while C. trachomatis was present in 34 patients (15%). In majority of female patients (112 out of 130; 86%) U. urealyticum was found. In addition to ureaplasma, in eight patients M. hominis was found. C. trachomatis was identified in 18 female patients (14%). In 74 out of 90 (82%) male patients U. urealyticum was detected while in six of them M. hominis was also found. C. trachomatis was identified in 16 male patients (18%). U. urealyticum was significantly related to leukocyturia, as opposed to C. trachomatis (p<0,001). Women had more frequent symptomatology (p = 0,015) and higer leukocyturia (p<0.001). Conclusion: Leukocyturia is more common find in U. Urealyticum infection than in patients with C. trachomatis infection. It is therefore advisable to test patients with uncomplicated reccurent UTIs for the presence of these atypical pathogens. Symptomatic patients, as well as their partners, should be treated accordingly. *Correspondence to: Jadranka Vlasic-Matas, Polyclinic Nephrology Department, Split, Croatia, Tel: 0038521317320; Fax: 0038521317322; E-mail: jadranka.vlasic-matas@st.t-com.hr","PeriodicalId":160607,"journal":{"name":"Nephrology and Renal Diseases","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132318926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Acute kidney injury (AKI): Risk assessment and management in hospital versus community 急性肾损伤(AKI):医院与社区的风险评估和管理

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000169

Kugananda Sri Paranthaman, M. Jawad

{"title":"Acute kidney injury (AKI): Risk assessment and management in hospital versus community","authors":"Kugananda Sri Paranthaman, M. Jawad","doi":"10.15761/nrd.1000169","DOIUrl":"https://doi.org/10.15761/nrd.1000169","url":null,"abstract":"A retrospective clinical audit undertaken at East Surrey looking at the risk assessment targeting modifiable risk factors and management of at-risk population of developing AKI in hospital versus community. The study was done over two 5-week periods over the span of 2 years which included 100 patients. The results concluded that 2 of the highest risk factors of developing AKI in hospital were patient co-morbidities (55%) and nephrotoxic medication (55%) where else hypovolemia (52%) was the biggest risk factor of developing AKI in the community. The results also noted overall better management of AKI in the community than in hospital, particularly regular nephrotoxic medication review (90%), fluid balance monitoring (64%), urine dip (75%) and blood gas on admission (76%). Advanced age (58% above the age of 75) and previous history of AKI are common significant risk factors in developing AKI in both groups. The study led to an action plan of developing the hospital AKI guideline, with tailored focus on risk assessment and prevention, which included streamlining management of patients with AKI using an AKI care bundle as well as creating an AKI electronic alert to identify patients admitted with previous history of AKI","PeriodicalId":160607,"journal":{"name":"Nephrology and Renal Diseases","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114765257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Patient and graft survival of deceased donor transplant in one year’s post kidney transplant Experience of single center, what does need for results to be better than this? 死亡供者移植后一年的患者和移植物存活率单中心经验，需要什么结果比这更好?

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000152

A. Zomorrodi, Abulfazel Bohluli, F. Kakei, Mohsen Mohammadrahimi

{"title":"Patient and graft survival of deceased donor transplant in one year’s post kidney transplant Experience of single center, what does need for results to be better than this?","authors":"A. Zomorrodi, Abulfazel Bohluli, F. Kakei, Mohsen Mohammadrahimi","doi":"10.15761/nrd.1000152","DOIUrl":"https://doi.org/10.15761/nrd.1000152","url":null,"abstract":"Until this time the best modality for treatment of end stage renal failure (ESRD) is kidney transplantation, but the most important problem with that is shortage of donor. A deceased donor is the main provider of kidney and a relative and unrelative live donor is secondary provider of kidney for transplantation. But in deceased donor in comparing with live donor there is not a time for complete evaluation and almost to be in bad condition for deceased donor so it seems that there will be some difference in deceased and live donor outcome. We investigated patient and graft survival in deceased donor in one year after Transplantation in our center. Material and method: From 2003 until 2018 in our center there were 88 ESRD patients between age of 12 to 67 years 33 females 55males that have been transplanted with deceased donors , donors( between ages 5to 60 years 12 females 35 males) but we just only approached 85 cases of recipients (43 males and 42 females) and investigated for patient and graft survival : all of recipients have been treated with induction of ATG and then triple medicines Sandimune or Tacrolimuse and prednisolone and Imuran Cellcept and operation have been carried out with one team of surgery. Results: 8 cases expired about in first 2 months of operation (8 case in early times) and 77 patients were live in one year (90/58%) and overall 16-allograft loss in one year ,69 allografts survived in one year (81/17%). Conclusion: In our center one-year graft survival was 81/17% and patient survival was 90/58% which results may be comparable with other centers and it seems that the result can be better than this in our center which we will discuss in this paper. *Correspondence to: Afshar Zomorrodi, Professor of urology and kidney transplant surgeon, Head of organ transplantation Department, Imam Reza hospital, Tabriz medical science University, Tabriz -Iran, E-mail: dr_zomorrodi@ yahoo.com","PeriodicalId":160607,"journal":{"name":"Nephrology and Renal Diseases","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123748886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nephrology and Renal Diseases Pub Date : 1900-01-01 DOI: 10.15761/nrd.1000178

Aluma Elkayam, Ahmed Abuleil, T Smmolken, A. Saed, N. Haia, Boshra Nasser, W. Nasser

引用次数: 0